Literature DB >> 18484656

Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2.

H Syed Iqbal1, P Balakrishnan, K G Murugavel, Solomon Suniti.   

Abstract

Diagnostic kits for the detection of human immunodeficiency virus (HIV) antibodies have reached an unprecedented number. But choice of an ideal, cost-effective, and rapid test for HIV infection is of immense value for use in developing countries like India, where resources are limited. In this study we have evaluated the performance characteristics of the rapid immunochromatographic HIV test kit First Response HIV 1-2.O. First, the laboratory archived 450 characterized plasma/serum specimens, which were tested on First Response HIV 1-2.O. Second, a total of 134 consecutive voluntary counseling and testing (VCT) specimens were also tested and positive specimens were further confirmed with HIV TRI-DOT. All these VCT specimens were cross-checked with HIV double-enzyme-linked immunosorbent assay (ELISA) (Murex and Vironostika), and the results were matched. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and efficiency of First Response HIV 1-2.O with the 450 characterized specimens was 100% for HIV-1 with reference assay. The results in the VCT algorithm were correlating with double-ELISA. In the HIV-2 analysis, five HIV-2-positive specimens in First Response HIV 1-2.O were found to be HIV-2-indeterminate on Western blot. HIV TRI-DOT was unable to pick up two HIV-2 Western blot-positive specimens. First Response HIV 1-2.O has several advantages: low-cost (U.S. $0.70); only 10 microL of specimen; involves only two steps; room temperature storage; ability to differentiate HIV-1 and 2; and use of whole blood specimen. Hence this test kit could be suitable for initial screening in the HIV testing algorithm in resource-limited settings. J. Clin. Lab. Anal. 22:178-185, 2008. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484656      PMCID: PMC6649098          DOI: 10.1002/jcla.20238

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  31 in total

1.  Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.

Authors:  Darrell E Singer; Noah Kiwanuka; David Serwadda; Fred Nalugoda; Linda Hird; Jamie Bulken-Hoover; Godfrey Kigozi; Jennifer A Malia; Eva K Calero; Warren Sateren; Merlin L Robb; Fred Wabwire-Mangen; Maria Wawer; Ronald H Gray; Nelson Sewankambo; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  The fallibility of HIV western blot.

Authors:  P P Mortimer
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

Review 3.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

4.  Evaluation and diagnostic usefulness of domestic and imported enzyme-linked immunosorbent assays for detection of human immunodeficiency virus type 1 antibody in India.

Authors:  H Syed Iqbal; Suniti Solomon; K G Murugavel; Sunil Suhas Solomon; P Balakrishnan
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

5.  Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa.

Authors:  Cédric Mahé; Pontiano Kaleebu; Amato Ojwiya; James A G Whitworth
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

6.  Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa.

Authors:  S Aidoo; W K Ampofo; J A Brandful; S V Nuvor; J K Ansah; N Nii-Trebi; J S Barnor; F Apeagyei; T Sata; D Ofori-Adjei; K Ishikawa
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Prevalence and risk factors of HIV-1 and HIV-2 infection in urban and rural areas in Tamil Nadu, India.

Authors:  S Solomon; N Kumarasamy; A K Ganesh; R E Amalraj
Journal:  Int J STD AIDS       Date:  1998-02       Impact factor: 1.359

8.  Performance evaluation of four different kits available in the Indian market, for the rapid detection of HIV antibody.

Authors:  R Kannangai; K Prabu; A A Vincent; T S Vijayakumar; G Sridharan
Journal:  Indian J Med Microbiol       Date:  2003 Jul-Sep       Impact factor: 0.985

9.  Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda).

Authors:  S C Kagulire; P D Stamper; P Opendi; J L Nakavuma; L A Mills; F Makumbi; R H Gray; D Serwadda; S J Reynolds
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

10.  Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.

Authors:  Sabelle Jallow; Steve Kaye; Abraham Alabi; Akum Aveika; Ramu Sarge-Njie; Saihou Sabally; Tumani Corrah; Hilton Whittle; Guido Vanham; Sarah Rowland-Jones; Wouter Janssens; Samuel J McConkey
Journal:  AIDS       Date:  2006-06-26       Impact factor: 4.177

View more
  6 in total

1.  A rapid ultrasound particle agglutination method for HIV antibody detection: Comparison with conventional rapid HIV tests.

Authors:  Simon Bystryak; Natalya Ossina
Journal:  J Virol Methods       Date:  2017-08-24       Impact factor: 2.014

2.  Rapid HIV testing program implementation: lessons from the emergency department.

Authors:  Christian Arbelaez; Brian Block; Elena Losina; Elizabeth A Wright; William M Reichmann; Regina Mikulinsky; Jessica D Solomon; Matthew M Dooley; Rochelle P Walensky
Journal:  Int J Emerg Med       Date:  2009-09-01

3.  Field Evaluation of Four Rapid Tests for Diagnosis of HIV Infection in Panama.

Authors:  Sandra I Juarez; Aurelio E Nuñez; Margginna M Aranda; Dalis Mojica; Andrea A Kim; Bharat Parekh
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

4.  Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.

Authors:  Kartik K Venkatesh; Jessica E Becker; Nagalingeswaran Kumarasamy; Yoriko M Nakamura; Kenneth H Mayer; Elena Losina; Soumya Swaminathan; Timothy P Flanigan; Rochelle P Walensky; Kenneth A Freedberg
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

5.  Contribution of the classical polymerase chain reaction in the diagnosis of a HIV-1 infected patient in Benin: a case report.

Authors:  Edmond Tchiakpe; René K Keke; Nicole Vidal; Moussa Bachabi; Flore Armande Gangbo; Halimatou Diop-Ndiaye; Coumba Toure-Kane; Akadiri Yessoufou
Journal:  AIDS Res Ther       Date:  2021-04-21       Impact factor: 2.250

6.  Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon.

Authors:  Jodie Dionne-Odom; Rahel Mbah; Nicole J Rembert; Samuel Tancho; Gregory E Halle-Ekane; Comfort Enah; Thomas K Welty; Pius M Tih; Alan T N Tita
Journal:  Infect Dis Obstet Gynecol       Date:  2016-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.